Ja. Prince et al., NEUROLEPTIC-INDUCED MITOCHONDRIAL ENZYME ALTERATIONS IN THE RAT-BRAIN, The Journal of pharmacology and experimental therapeutics, 280(1), 1997, pp. 261-267
For years, it has been known that neuroleptics have the capacity to in
terfere with the mitochondrial respiratory chain in vitro. We report t
hat haloperidol and fluphenazine, classical neuroleptics, cause a gene
ralized reduction in the activity of NADH: ubiquinone oxidoreductase (
complex I) in the rat brain in vivo, an effect that was not observed w
ith the atypical neuroleptic, clozapine. MPTP, which bears significant
structural similarities with haloperidol, also demonstrated a signifi
cant reduction in complex I activity after low-dose, chronic administr
ation. Interestingly, an increase in the activity of cytochrome-c oxid
ase (complex IV), probably reflecting enhanced functional neuronal act
ivity, was observed in the frontal cortex of all chronically treated a
nimals, an effect that is unlikely to result from compensation for the
inhibition of complex I. Results suggest that previous findings, in w
hich a reduction in the activity of cytochrome-c oxidase was observed
in postmortem brain samples from schizophrenics, are not dependent on
treatment with neuroleptics.